# Philippe Corcia

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philippe-corcia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,443 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 51 |
| i10-index | 173 |
| Last Known Institution | Université de Tours |
| OpenAlex ID | https://openalex.org/A5024570101 |
| ORCID iD | 0000-0002-1625-8845 |
| Works | 371 |

## Researcher papers

- [Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis](https://scholariq.org/papers/genome-wide-association-analyses-identify-new-risk-variants-and-the-genetic/)
- [Primary lateral sclerosis: consensus diagnostic criteria](https://scholariq.org/papers/primary-lateral-sclerosis-consensus-diagnostic-criteria/)
- [Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis](https://scholariq.org/papers/molecular-imaging-of-microglial-activation-in-amyotrophic-lateral-sclerosis/)
- [The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?](https://scholariq.org/papers/the-debated-toxic-role-of-aggregated-tdp-43-in-amyotrophic-lateral-sclerosis-a/)
- [Reduced expression of the <i>Kinesin-Associated Protein 3</i> ( <i>KIFAP3</i> ) gene increases survival in sporadic amyotrophic lateral sclerosis](https://scholariq.org/papers/reduced-expression-of-the-i-kinesin-associated-protein-3-i-i-kifap3-i-gene/)
- [Causes of death in a post‐mortem series of ALS patients](https://scholariq.org/papers/causes-of-death-in-a-post-mortem-series-of-als-patients/)
- [Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study](https://scholariq.org/papers/causes-of-death-amongst-french-patients-with-amyotrophic-lateral-sclerosis-a/)
- [Impaired glucose tolerance in patients with amyotrophic lateral sclerosis](https://scholariq.org/papers/impaired-glucose-tolerance-in-patients-with-amyotrophic-lateral-sclerosis/)
- [Phenotype difference between ALS patients with expanded repeats in <i>C9ORF72</i> and patients with mutations in other ALS-related genes](https://scholariq.org/papers/phenotype-difference-between-als-patients-with-expanded-repeats-in-i-c9orf72-i/)
- [The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development](https://scholariq.org/papers/the-glutamate-hypothesis-in-als-pathophysiology-and-drug-development/)
- [EE657 Health Resource Utilization by Disease Stage for People with Amyotrophic Lateral Sclerosis (pALS) in the French National Health Data System (SNDS)](https://scholariq.org/papers/ee657-health-resource-utilization-by-disease-stage-for-people-with-amyotrophic/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)

## Researcher university

- [Université de Tours](https://scholariq.org/institutions/universite-de-tours/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.